DuPont de Nemours, Inc., commonly shortened to DuPont, headquartered and organized in Delaware, produces products for the healthcare, water, construction and industrial markets. It was formed in 1802 by French-American chemist and industrialist Éleuthère Irénée du Pont de Nemours.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| DD | DuPont de Nemours, Inc. | 2026-05-29 15:14:17 | 48.42 | 0.68 | 1.42 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DD | 0001666700 | DuPont de Nemours, Inc. | US26614N1028 | 5493004JF0SDFLM8GD76 | 811224539 | NYSE | 2821 | Plastic Materials, Synth Resins & Nonvulcan Elastomers | 1231 | DE | 974 CENTRE ROAD | WILMINGTON | DE | 19805 | UNITED STATES | US | (302) 295-5783 | 974 CENTRE ROAD, WILMINGTON, DE, 19805 | 974 CENTRE ROAD, WILMINGTON, DE, 19805 | DowDuPont Inc. | Materials | 1802 | Lori Koch | 15,000 | http://dupont.com | 12,000,000,000 | 409,867,418 | 409,921,306 | DuPont de Nemours, Inc., commonly shortened to DuPont, headquartered and organized in Delaware, produces products for the healthcare, water, construction and industrial markets. It was formed in 1802 by French-American chemist and industrialist Éleuthère Irénée du Pont de Nemours. | 2026-05-28 15:41:39 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 12,000,000,000 | -22,000,000,000 | -64.7059 | 408,923,857 | -9,125,270 | -2.1828 |
| 2024 | 34,000,000,000 | 1,000,000,000 | 3.0303 | 418,049,127 | 466,263 | 0.1117 |
| 2023 | 33,000,000,000 | 5,000,000,000 | 17.8571 | 417,582,864 | -40,755,188 | -8.8919 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Jeroen P. Bloemhard | President | 2025 | 545,833 | 400,000 | 750,037 | 474,375 | 84,354 | 2,254,599 |
| Erik T. Hoover | General Counsel, Senior Vice President | 2025 | 687,500 | 0 | 2,000,017 | 708,400 | 134,260 | 3,530,177 |
| Lori D. Koch | Chief Executive Officer | 2025 | 1,242,313 | 0 | 12,547,711 | 1,897,500 | 446,726 | 16,134,250 |
| Antonella B. Franzen | Chief Financial Officer, Senior Vice President | 2025 | 741,667 | 0 | 3,136,972 | 872,850 | 188,685 | 4,940,174 |
| Christopher P. Raia | Chief Human Resources Officer, Senior Vice President | 2025 | 566,667 | 0 | 1,750,004 | 494,615 | 104,930 | 2,916,216 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 15,000 |
| 2024 | 24,000 |
| 2023 | 24,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 6,849,000,000 | 12,386,000,000 | 12,068,000,000 |
| Cost Of Revenue | 4,486,000,000 | 7,879,000,000 | 7,835,000,000 |
| Gross Profit | 2,363,000,000 | 4,507,000,000 | 4,233,000,000 |
| Research And Development Expenses | 193,000,000 | 531,000,000 | 508,000,000 |
| General And Administrative Expenses | 1,019,000,000 | 1,552,000,000 | 1,408,000,000 |
| Operating Expenses | 2,163,000,000 | 3,315,000,000 | 3,729,000,000 |
| Operating Income | 200,000,000 | 1,192,000,000 | 504,000,000 |
| Net Income | -779,000,000 | 703,000,000 | 423,000,000 |
| Earnings Per Share Basic | -1.87 | 1.68 | 0.94 |
| Earnings Per Share Diluted | -1.86 | 1.67 | 0.94 |
| Weighted Average Shares Outstanding Basic | 417,500,000 | 419,200,000 | 449,900,000 |
| Weighted Average Shares Outstanding Diluted | 419,200,000 | 420,600,000 | 451,200,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 42,000,000 | 42,000,000 | 411,000,000 |
| Marketable Securities Current | — | — | 0 |
| Accounts Receivable | 1,669,000,000 | 2,199,000,000 | 2,370,000,000 |
| Inventories | 1,172,000,000 | 2,130,000,000 | 2,147,000,000 |
| Non Trade Receivables | 250,000,000 | 584,000,000 | 556,000,000 |
| Other Assets Current | 121,000,000 | 179,000,000 | 194,000,000 |
| Total Assets Current | 5,575,000,000 | 6,364,000,000 | 7,514,000,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 3,464,000,000 | 5,768,000,000 | 5,884,000,000 |
| Other Assets Non Current | 971,000,000 | 1,204,000,000 | 1,237,000,000 |
| Total Assets Non Current | 3,464,000,000 | 5,768,000,000 | 5,884,000,000 |
| Total Assets | 21,575,000,000 | 36,636,000,000 | 38,552,000,000 |
| Accounts Payable | 995,000,000 | 1,720,000,000 | 1,675,000,000 |
| Deferred Revenue | — | 2,000,000 | 1,000,000 |
| Short Term Debt | 60,000,000 | 1,848,000,000 | 0 |
| Other Liabilities Current | 882,000,000 | 1,031,000,000 | 1,269,000,000 |
| Total Liabilities Current | 2,305,000,000 | 4,801,000,000 | 3,098,000,000 |
| Long Term Debt | 3,134,000,000 | 5,323,000,000 | 7,859,000,000 |
| Other Liabilities Non Current | 1,196,000,000 | 1,281,000,000 | 1,234,000,000 |
| Total Liabilities Non Current | 5,167,000,000 | 8,042,000,000 | 10,729,000,000 |
| Total Liabilities | 7,472,000,000 | 12,843,000,000 | 13,827,000,000 |
| Common Stock | 4,000,000 | 4,000,000 | 4,000,000 |
| Retained Earnings | -24,278,000,000 | -23,076,000,000 | -22,874,000,000 |
| Accumulated Other Comprehensive Income | -525,000,000 | -1,500,000,000 | -910,000,000 |
| Total Shareholders Equity | 13,919,000,000 | 23,350,000,000 | 24,279,000,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 647,000,000 | 1,194,000,000 | 1,147,000,000 |
| Share Based Compensation Expense | 38,000,000 | 77,000,000 | — |
| Other Non Cash Income Expense | -36,000,000 | 27,000,000 | -128,000,000 |
| Change In Accounts Receivable | 201,000,000 | 135,000,000 | -202,000,000 |
| Change In Inventories | — | — | — |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | 61,000,000 | 77,000,000 | -310,000,000 |
| Change In Other Liabilities | 163,000,000 | -287,000,000 | 274,000,000 |
| Cash From Operating Activities | 560,000,000 | 2,321,000,000 | 2,191,000,000 |
| Purchases Of Marketable Securities | 0 | 0 | 32,000,000 |
| Sales Of Marketable Securities | 0 | 0 | 1,334,000,000 |
| Acquisition Of Property Plant And Equipment | 333,000,000 | 579,000,000 | 619,000,000 |
| Acquisition Of Business | 55,000,000 | 321,000,000 | 1,761,000,000 |
| Other Investing Activities | -14,000,000 | -43,000,000 | -6,000,000 |
| Cash From Investing Activities | -313,000,000 | 0 | -33,000,000 |
| Tax Withholding For Share Based Compensation | 26,000,000 | 27,000,000 | 27,000,000 |
| Payments Of Dividends | 597,000,000 | 635,000,000 | 651,000,000 |
| Issuance Of Common Stock | 32,000,000 | 50,000,000 | 27,000,000 |
| Repurchase Of Common Stock | 500,000,000 | — | — |
| Issuance Of Long Term Debt | — | 0 | 0 |
| Repayment Of Long Term Debt | 4,134,000,000 | — | — |
| Other Financing Activities | -4,000,000 | -1,000,000 | -1,000,000 |
| Cash From Financing Activities | -1,750,000,000 | -1,847,000,000 | -2,989,000,000 |
| Change In Cash | -1,132,000,000 | -911,000,000 | -969,000,000 |
| Cash At End Of Period | 42,000,000 | 42,000,000 | 411,000,000 |
| Income Taxes Paid | 127,000,000 | — | — |
| Interest Paid | — | — | — |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | -1.87 | 1.68 | 0.94 |
| Price To Earnings Ratio | -21.4973 | 18.7273 | 33.7686 |
| Earnings Growth Rate | -211.3095 | 78.7234 | -92.0136 |
| Price Earnings To Growth Ratio | 0.1017 | 0.2379 | -0.367 |
| Book Value Per Share | 33.7796 | 56.7581 | 54.9567 |
| Price To Book Ratio | 1.1901 | 0.5543 | 0.5776 |
| Ebitda | -5,000,000 | 1,897,000,000 | 1,570,000,000 |
| Enterprise Value | 19,935,500,000 | 20,317,828,480 | 21,728,950,750 |
| Dividend Yield | 0.0356 | 0.0481 | 0.0456 |
| Dividend Payout Ratio | -0.7664 | 0.9033 | 1.539 |
| Debt To Equity Ratio | 0.2295 | 0.3071 | 0.3237 |
| Capital Expenditures | -1,657,000,000 | 1,078,000,000 | 1,300,000,000 |
| Free Cash Flow | 2,217,000,000 | 1,243,000,000 | 891,000,000 |
| Return On Equity | -0.056 | 0.0301 | 0.0174 |
| One Year Beta | 1.328 | 0.742 | 1.0493 |
| Three Year Beta | 1.1245 | 0.985 | 1.0437 |
| Five Year Beta | 1.0818 | 1.0992 | 1.1341 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Brady Amy G. | Director | 2026-05-21 | 4,030 | A | 23,780 |
| CHANDY RUBY R | Director | 2026-05-21 | 4,030 | A | 25,444 |
| CUTLER ALEXANDER M | Director | 2026-05-21 | 4,030 | A | 80,761 |
| du Pont Eleuthere I | Director | 2026-05-21 | 4,030 | A | 42,371 |
| LICO JAMES A | Director | 2026-05-21 | 4,030 | A | 10,839 |
| Name Of Reporting Person | Type Of Reporting Person | Report Date | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| David A Perdue , Jr | Senator | 2021-05-02 | Purchase | 2020-02-27 | Joint | $1,001 - $15,000 |
| David A Perdue , Jr | Senator | 2021-05-02 | Purchase | 2020-02-28 | Joint | $1,001 - $15,000 |
| David A Perdue , Jr | Senator | 2021-05-02 | Purchase | 2020-02-28 | Joint | $1,001 - $15,000 |
| David A Perdue , Jr | Senator | 2021-05-02 | Sale (Full) | 2020-04-14 | Joint | $50,001 - $100,000 |
| David A Perdue , Jr | Senator | 2021-05-02 | Purchase | 2020-02-27 | Joint | $1,001 - $15,000 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Gilbert Cisneros | 2026-02-13 | CA31 | Purchase | 2026-01-09 | — | $1,001 - $15,000 |
| Gilbert Cisneros | 2025-12-15 | CA31 | Sale | 2025-11-12 | — | $1,001 - $15,000 |
| Rob Bresnahan | 2025-06-09 | PA08 | Sale | 2025-05-15 | — | $1,001 - $15,000 |
| Jefferson Shreve | 2025-04-11 | IN06 | Sale | 2025-03-31 | — | $15,001 - $50,000 |
| Lois Frankel | 2023-10-10 | FL22 | Sale | 2023-09-08 | — | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Asset Dedication, LLC | 2026-03-31 | 240,858 | 5,259 | 45.7992 |
| GLENMEDE TRUST CO NA | 2026-03-31 | 10,412,720 | 227,352 | 45.8 |
| GROUPAMA ASSET MANAGMENT | 2026-03-31 | 205,047 | 4,477 | 45.8001 |
| SOA Wealth Advisors, LLC. | 2026-03-31 | 2,462 | 54 | 45.5926 |
| Western Wealth Management, LLC | 2026-03-31 | 82,071 | 1,792 | 45.7985 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| CYBER HORNET TRUST | 2026-03-31 | CYBER HORNET S&P 500(R) and Bitcoin 75/25 Strategy ETF | BBB | 37 | 1,694.6 | 0.0253 |
| UBS FUNDS | 2026-03-31 | CLASS P | BPGLX | 251 | 11,495.8 | 0.0082 |
| UBS FUNDS | 2026-03-31 | CLASS A | BNGLX | 251 | 11,495.8 | 0.0082 |
| J.P. Morgan Exchange-Traded Fund Trust | 2026-03-31 | JPMorgan Equity Premium Yield ETF | ROCY | 5,407 | 247,640.6 | 0.2353 |
| J.P. Morgan Exchange-Traded Fund Trust | 2026-03-31 | JPMorgan Fundamental Data Science Large Value ETF | LVDS | 5,023 | 230,053.4 | 0.2424 |